The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Autotransfusion Systems (ATS) Market Research Report 2025
Synopsis
Autotransfusion System (ATS) is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures. Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The global Autotransfusion Systems (ATS) market was valued at US$ 423.8 million in 2023 and is anticipated to reach US$ 568.2 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
North American market for Autotransfusion Systems (ATS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Autotransfusion Systems (ATS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Autotransfusion Systems (ATS) include BD (Bard), LivaNova, Fresenius Kabi, Haemonetics and Medtronic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Autotransfusion Systems (ATS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autotransfusion Systems (ATS).
Report Scope
The Autotransfusion Systems (ATS) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autotransfusion Systems (ATS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autotransfusion Systems (ATS) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD (Bard)
LivaNova
Fresenius Kabi
Haemonetics
Medtronic
Segment by Type
Continuous Autotransfusion Systems
Discontinuous Autotransfusion Systems
Segment by Application
Cardiac Surgery
Non-Cardiac Surgery
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Autotransfusion Systems (ATS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Autotransfusion Systems (ATS) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Autotransfusion System (ATS) is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures. Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The global Autotransfusion Systems (ATS) market was valued at US$ 423.8 million in 2023 and is anticipated to reach US$ 568.2 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
North American market for Autotransfusion Systems (ATS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Autotransfusion Systems (ATS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Autotransfusion Systems (ATS) include BD (Bard), LivaNova, Fresenius Kabi, Haemonetics and Medtronic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Autotransfusion Systems (ATS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autotransfusion Systems (ATS).
Report Scope
The Autotransfusion Systems (ATS) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autotransfusion Systems (ATS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autotransfusion Systems (ATS) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD (Bard)
LivaNova
Fresenius Kabi
Haemonetics
Medtronic
Segment by Type
Continuous Autotransfusion Systems
Discontinuous Autotransfusion Systems
Segment by Application
Cardiac Surgery
Non-Cardiac Surgery
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Autotransfusion Systems (ATS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Autotransfusion Systems (ATS) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Autotransfusion Systems (ATS) Market Overview
1.1 Product Overview and Scope of Autotransfusion Systems (ATS)
1.2 Autotransfusion Systems (ATS) Segment by Type
1.2.1 Global Autotransfusion Systems (ATS) Market Value Comparison by Type (2024-2030)
1.2.2 Continuous Autotransfusion Systems
1.2.3 Discontinuous Autotransfusion Systems
1.3 Autotransfusion Systems (ATS) Segment by Application
1.3.1 Global Autotransfusion Systems (ATS) Market Value by Application: (2024-2030)
1.3.2 Cardiac Surgery
1.3.3 Non-Cardiac Surgery
1.4 Global Autotransfusion Systems (ATS) Market Size Estimates and Forecasts
1.4.1 Global Autotransfusion Systems (ATS) Revenue 2019-2030
1.4.2 Global Autotransfusion Systems (ATS) Sales 2019-2030
1.4.3 Global Autotransfusion Systems (ATS) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Autotransfusion Systems (ATS) Market Competition by Manufacturers
2.1 Global Autotransfusion Systems (ATS) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Autotransfusion Systems (ATS) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Autotransfusion Systems (ATS) Average Price by Manufacturers (2019-2024)
2.4 Global Autotransfusion Systems (ATS) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Autotransfusion Systems (ATS), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Autotransfusion Systems (ATS), Product Type & Application
2.7 Autotransfusion Systems (ATS) Market Competitive Situation and Trends
2.7.1 Autotransfusion Systems (ATS) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Autotransfusion Systems (ATS) Players Market Share by Revenue
2.7.3 Global Autotransfusion Systems (ATS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Autotransfusion Systems (ATS) Retrospective Market Scenario by Region
3.1 Global Autotransfusion Systems (ATS) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Autotransfusion Systems (ATS) Global Autotransfusion Systems (ATS) Sales by Region: 2019-2030
3.2.1 Global Autotransfusion Systems (ATS) Sales by Region: 2019-2024
3.2.2 Global Autotransfusion Systems (ATS) Sales by Region: 2025-2030
3.3 Global Autotransfusion Systems (ATS) Global Autotransfusion Systems (ATS) Revenue by Region: 2019-2030
3.3.1 Global Autotransfusion Systems (ATS) Revenue by Region: 2019-2024
3.3.2 Global Autotransfusion Systems (ATS) Revenue by Region: 2025-2030
3.4 North America Autotransfusion Systems (ATS) Market Facts & Figures by Country
3.4.1 North America Autotransfusion Systems (ATS) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Autotransfusion Systems (ATS) Sales by Country (2019-2030)
3.4.3 North America Autotransfusion Systems (ATS) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Autotransfusion Systems (ATS) Market Facts & Figures by Country
3.5.1 Europe Autotransfusion Systems (ATS) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Autotransfusion Systems (ATS) Sales by Country (2019-2030)
3.5.3 Europe Autotransfusion Systems (ATS) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Autotransfusion Systems (ATS) Market Facts & Figures by Country
3.6.1 Asia Pacific Autotransfusion Systems (ATS) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Autotransfusion Systems (ATS) Sales by Country (2019-2030)
3.6.3 Asia Pacific Autotransfusion Systems (ATS) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Autotransfusion Systems (ATS) Market Facts & Figures by Country
3.7.1 Latin America Autotransfusion Systems (ATS) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Autotransfusion Systems (ATS) Sales by Country (2019-2030)
3.7.3 Latin America Autotransfusion Systems (ATS) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Autotransfusion Systems (ATS) Market Facts & Figures by Country
3.8.1 Middle East and Africa Autotransfusion Systems (ATS) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Autotransfusion Systems (ATS) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Autotransfusion Systems (ATS) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Autotransfusion Systems (ATS) Sales by Type (2019-2030)
4.1.1 Global Autotransfusion Systems (ATS) Sales by Type (2019-2024)
4.1.2 Global Autotransfusion Systems (ATS) Sales by Type (2025-2030)
4.1.3 Global Autotransfusion Systems (ATS) Sales Market Share by Type (2019-2030)
4.2 Global Autotransfusion Systems (ATS) Revenue by Type (2019-2030)
4.2.1 Global Autotransfusion Systems (ATS) Revenue by Type (2019-2024)
4.2.2 Global Autotransfusion Systems (ATS) Revenue by Type (2025-2030)
4.2.3 Global Autotransfusion Systems (ATS) Revenue Market Share by Type (2019-2030)
4.3 Global Autotransfusion Systems (ATS) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Autotransfusion Systems (ATS) Sales by Application (2019-2030)
5.1.1 Global Autotransfusion Systems (ATS) Sales by Application (2019-2024)
5.1.2 Global Autotransfusion Systems (ATS) Sales by Application (2025-2030)
5.1.3 Global Autotransfusion Systems (ATS) Sales Market Share by Application (2019-2030)
5.2 Global Autotransfusion Systems (ATS) Revenue by Application (2019-2030)
5.2.1 Global Autotransfusion Systems (ATS) Revenue by Application (2019-2024)
5.2.2 Global Autotransfusion Systems (ATS) Revenue by Application (2025-2030)
5.2.3 Global Autotransfusion Systems (ATS) Revenue Market Share by Application (2019-2030)
5.3 Global Autotransfusion Systems (ATS) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BD (Bard)
6.1.1 BD (Bard) Corporation Information
6.1.2 BD (Bard) Description and Business Overview
6.1.3 BD (Bard) Autotransfusion Systems (ATS) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BD (Bard) Autotransfusion Systems (ATS) Product Portfolio
6.1.5 BD (Bard) Recent Developments/Updates
6.2 LivaNova
6.2.1 LivaNova Corporation Information
6.2.2 LivaNova Description and Business Overview
6.2.3 LivaNova Autotransfusion Systems (ATS) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 LivaNova Autotransfusion Systems (ATS) Product Portfolio
6.2.5 LivaNova Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Autotransfusion Systems (ATS) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fresenius Kabi Autotransfusion Systems (ATS) Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Haemonetics
6.4.1 Haemonetics Corporation Information
6.4.2 Haemonetics Description and Business Overview
6.4.3 Haemonetics Autotransfusion Systems (ATS) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Haemonetics Autotransfusion Systems (ATS) Product Portfolio
6.4.5 Haemonetics Recent Developments/Updates
6.5 Medtronic
6.5.1 Medtronic Corporation Information
6.5.2 Medtronic Description and Business Overview
6.5.3 Medtronic Autotransfusion Systems (ATS) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Medtronic Autotransfusion Systems (ATS) Product Portfolio
6.5.5 Medtronic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Autotransfusion Systems (ATS) Industry Chain Analysis
7.2 Autotransfusion Systems (ATS) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Autotransfusion Systems (ATS) Production Mode & Process
7.4 Autotransfusion Systems (ATS) Sales and Marketing
7.4.1 Autotransfusion Systems (ATS) Sales Channels
7.4.2 Autotransfusion Systems (ATS) Distributors
7.5 Autotransfusion Systems (ATS) Customers
8 Autotransfusion Systems (ATS) Market Dynamics
8.1 Autotransfusion Systems (ATS) Industry Trends
8.2 Autotransfusion Systems (ATS) Market Drivers
8.3 Autotransfusion Systems (ATS) Market Challenges
8.4 Autotransfusion Systems (ATS) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Autotransfusion Systems (ATS) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Autotransfusion Systems (ATS) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Autotransfusion Systems (ATS) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Autotransfusion Systems (ATS) Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Autotransfusion Systems (ATS) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Autotransfusion Systems (ATS) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Autotransfusion Systems (ATS) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Autotransfusion Systems (ATS) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Autotransfusion Systems (ATS), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Autotransfusion Systems (ATS), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Autotransfusion Systems (ATS), Product Type & Application
Table 12. Global Key Manufacturers of Autotransfusion Systems (ATS), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Autotransfusion Systems (ATS) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autotransfusion Systems (ATS) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Autotransfusion Systems (ATS) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Autotransfusion Systems (ATS) Sales by Region (2019-2024) & (K Units)
Table 18. Global Autotransfusion Systems (ATS) Sales Market Share by Region (2019-2024)
Table 19. Global Autotransfusion Systems (ATS) Sales by Region (2025-2030) & (K Units)
Table 20. Global Autotransfusion Systems (ATS) Sales Market Share by Region (2025-2030)
Table 21. Global Autotransfusion Systems (ATS) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Autotransfusion Systems (ATS) Revenue Market Share by Region (2019-2024)
Table 23. Global Autotransfusion Systems (ATS) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Autotransfusion Systems (ATS) Revenue Market Share by Region (2025-2030)
Table 25. North America Autotransfusion Systems (ATS) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Autotransfusion Systems (ATS) Sales by Country (2019-2024) & (K Units)
Table 27. North America Autotransfusion Systems (ATS) Sales by Country (2025-2030) & (K Units)
Table 28. North America Autotransfusion Systems (ATS) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Autotransfusion Systems (ATS) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Autotransfusion Systems (ATS) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Autotransfusion Systems (ATS) Sales by Country (2019-2024) & (K Units)
Table 32. Europe Autotransfusion Systems (ATS) Sales by Country (2025-2030) & (K Units)
Table 33. Europe Autotransfusion Systems (ATS) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Autotransfusion Systems (ATS) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Autotransfusion Systems (ATS) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Autotransfusion Systems (ATS) Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Autotransfusion Systems (ATS) Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Autotransfusion Systems (ATS) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Autotransfusion Systems (ATS) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Autotransfusion Systems (ATS) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Autotransfusion Systems (ATS) Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Autotransfusion Systems (ATS) Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Autotransfusion Systems (ATS) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Autotransfusion Systems (ATS) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Autotransfusion Systems (ATS) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Autotransfusion Systems (ATS) Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Autotransfusion Systems (ATS) Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Autotransfusion Systems (ATS) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Autotransfusion Systems (ATS) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Autotransfusion Systems (ATS) Sales (K Units) by Type (2019-2024)
Table 51. Global Autotransfusion Systems (ATS) Sales (K Units) by Type (2025-2030)
Table 52. Global Autotransfusion Systems (ATS) Sales Market Share by Type (2019-2024)
Table 53. Global Autotransfusion Systems (ATS) Sales Market Share by Type (2025-2030)
Table 54. Global Autotransfusion Systems (ATS) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Autotransfusion Systems (ATS) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Autotransfusion Systems (ATS) Revenue Market Share by Type (2019-2024)
Table 57. Global Autotransfusion Systems (ATS) Revenue Market Share by Type (2025-2030)
Table 58. Global Autotransfusion Systems (ATS) Price (USD/Unit) by Type (2019-2024)
Table 59. Global Autotransfusion Systems (ATS) Price (USD/Unit) by Type (2025-2030)
Table 60. Global Autotransfusion Systems (ATS) Sales (K Units) by Application (2019-2024)
Table 61. Global Autotransfusion Systems (ATS) Sales (K Units) by Application (2025-2030)
Table 62. Global Autotransfusion Systems (ATS) Sales Market Share by Application (2019-2024)
Table 63. Global Autotransfusion Systems (ATS) Sales Market Share by Application (2025-2030)
Table 64. Global Autotransfusion Systems (ATS) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Autotransfusion Systems (ATS) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Autotransfusion Systems (ATS) Revenue Market Share by Application (2019-2024)
Table 67. Global Autotransfusion Systems (ATS) Revenue Market Share by Application (2025-2030)
Table 68. Global Autotransfusion Systems (ATS) Price (USD/Unit) by Application (2019-2024)
Table 69. Global Autotransfusion Systems (ATS) Price (USD/Unit) by Application (2025-2030)
Table 70. BD (Bard) Corporation Information
Table 71. BD (Bard) Description and Business Overview
Table 72. BD (Bard) Autotransfusion Systems (ATS) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. BD (Bard) Autotransfusion Systems (ATS) Product
Table 74. BD (Bard) Recent Developments/Updates
Table 75. LivaNova Corporation Information
Table 76. LivaNova Description and Business Overview
Table 77. LivaNova Autotransfusion Systems (ATS) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. LivaNova Autotransfusion Systems (ATS) Product
Table 79. LivaNova Recent Developments/Updates
Table 80. Fresenius Kabi Corporation Information
Table 81. Fresenius Kabi Description and Business Overview
Table 82. Fresenius Kabi Autotransfusion Systems (ATS) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Fresenius Kabi Autotransfusion Systems (ATS) Product
Table 84. Fresenius Kabi Recent Developments/Updates
Table 85. Haemonetics Corporation Information
Table 86. Haemonetics Description and Business Overview
Table 87. Haemonetics Autotransfusion Systems (ATS) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Haemonetics Autotransfusion Systems (ATS) Product
Table 89. Haemonetics Recent Developments/Updates
Table 90. Medtronic Corporation Information
Table 91. Medtronic Description and Business Overview
Table 92. Medtronic Autotransfusion Systems (ATS) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Medtronic Autotransfusion Systems (ATS) Product
Table 94. Medtronic Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Autotransfusion Systems (ATS) Distributors List
Table 98. Autotransfusion Systems (ATS) Customers List
Table 99. Autotransfusion Systems (ATS) Market Trends
Table 100. Autotransfusion Systems (ATS) Market Drivers
Table 101. Autotransfusion Systems (ATS) Market Challenges
Table 102. Autotransfusion Systems (ATS) Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Autotransfusion Systems (ATS)
Figure 2. Global Autotransfusion Systems (ATS) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Autotransfusion Systems (ATS) Market Share by Type in 2023 & 2030
Figure 4. Continuous Autotransfusion Systems Product Picture
Figure 5. Discontinuous Autotransfusion Systems Product Picture
Figure 6. Global Autotransfusion Systems (ATS) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Autotransfusion Systems (ATS) Market Share by Application in 2023 & 2030
Figure 8. Cardiac Surgery
Figure 9. Non-Cardiac Surgery
Figure 10. Global Autotransfusion Systems (ATS) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Autotransfusion Systems (ATS) Market Size (2019-2030) & (US$ Million)
Figure 12. Global Autotransfusion Systems (ATS) Sales (2019-2030) & (K Units)
Figure 13. Global Autotransfusion Systems (ATS) Average Price (USD/Unit) & (2019-2030)
Figure 14. Autotransfusion Systems (ATS) Report Years Considered
Figure 15. Autotransfusion Systems (ATS) Sales Share by Manufacturers in 2023
Figure 16. Global Autotransfusion Systems (ATS) Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Autotransfusion Systems (ATS) Players: Market Share by Revenue in 2023
Figure 18. Autotransfusion Systems (ATS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Autotransfusion Systems (ATS) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Autotransfusion Systems (ATS) Sales Market Share by Country (2019-2030)
Figure 21. North America Autotransfusion Systems (ATS) Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Autotransfusion Systems (ATS) Sales Market Share by Country (2019-2030)
Figure 25. Europe Autotransfusion Systems (ATS) Revenue Market Share by Country (2019-2030)
Figure 26. Germany Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Autotransfusion Systems (ATS) Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Autotransfusion Systems (ATS) Revenue Market Share by Region (2019-2030)
Figure 33. China Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Autotransfusion Systems (ATS) Sales Market Share by Country (2019-2030)
Figure 44. Latin America Autotransfusion Systems (ATS) Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Autotransfusion Systems (ATS) Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Autotransfusion Systems (ATS) Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Autotransfusion Systems (ATS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Autotransfusion Systems (ATS) by Type (2019-2030)
Figure 54. Global Revenue Market Share of Autotransfusion Systems (ATS) by Type (2019-2030)
Figure 55. Global Autotransfusion Systems (ATS) Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Autotransfusion Systems (ATS) by Application (2019-2030)
Figure 57. Global Revenue Market Share of Autotransfusion Systems (ATS) by Application (2019-2030)
Figure 58. Global Autotransfusion Systems (ATS) Price (USD/Unit) by Application (2019-2030)
Figure 59. Autotransfusion Systems (ATS) Value Chain
Figure 60. Autotransfusion Systems (ATS) Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
